Manila Gaddh

Department of Hematology and Medical Oncology
Associate Professor

manila.gaddh@emory.edu

Academic Appointment

Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

MBBS from Lady Hardinge Medical College

Research

Focus

My research focus is on thrombosis in cancer patients and bone marrow failure syndromes. I am currently involved in developing an evidence-based algorithmic approach to evaluation of thrombotic disorders, and am working towards exploring the feasibility of novel therapies, including combined thrombectomy and low dose anticoagulation, for treatment of thrombosis in cancer patients.

Publications

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
Chest Volume: 165 Page(s): 785 - 799
04/01/2024 Authors: Greenstein YY; Hubel K; Froess J; Wisniewski SR; Venugopal V; Lai Y-H; Berger JS; Chang SY; Colovos C; Shah F
Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen.
Blood Volume: 140 Page(s): 1983 - 1992
11/03/2022 Authors: Simon B; Cegldi A; Dolgos J; Farkas P; Gaddh M; Hank L; Horvth R; Kaposi A; Magyar L; Masszi T
Preliminary Analysis of the Symptoms and Quality of Life After Discharge in Noncritically Ill Patients with COVID-19: The ACTIV-4a and ATTACC Randomized Controlled Trial
Volume: 205
05/01/2022 Authors: Hubel KA; Greenstein YY; Venugopal V; Lai Y; Berger JS; Chang SY; Colovos C; Shah F; Islam M; Jimenez J
Preliminary Analysis of the Association Between Therapeutic-Dose Anticoagulation and Long Term Outcomes from the ACTIV-4a and ATTACC Multiplatform Adaptive Trial of Hospitalized Patients with COVID-19
Volume: 205
05/01/2022 Authors: Greenstein YY; Hubel K; Venugopal V; Lai Y; Berger JS; Chang SY; Colovos C; Shah FA; Islam M; Ceja JJ
Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment.
Res Pract Thromb Haemost Volume: 6 Page(s): e12740
05/01/2022 Authors: Groat D; Martin KA; Rosovsky RP; Sanfilippo KM; Gaddh M; Kreuziger LB; Eyster ME; Woller SC; Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group
Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.
EJHaem Volume: 3 Page(s): 457 - 462
05/01/2022 Authors: Scott LC; Li J; Cafuir LA; Gaddh M; Kempton CL
Clinical Outcomes of Critically III Patients with COVID-19 by Race.
J Racial Ethn Health Disparities Volume: 9 Page(s): 385 - 389
04/01/2022 Authors: Marmarchi F; Liu M; Rangaraju S; Auld SC; Creel-Bulos MC; Kempton CL; Sharifpour M; Gaddh M; Sniecinski R; Maier CL
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
Blood Adv Volume: 5 Page(s): 5546 - 5553
12/28/2021 Authors: Carney BJ; Wang T-F; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A
Comparative Analysis of Direct Oral Anticoagulants and Vitamin K Antagonists in Antiphospholipid Syndrome Patients
Volume: 138
11/23/2021 Authors: Elsebaie MAT; Wickham ZA; Debragga S; Li J; Gaddh M
County-Level Social Vulnerability Is Associated with Increased Risk for Venous Thromboembolism in COVID-19
Volume: 233 Page(s): S319 - S319
11/01/2021 Authors: Meena RA; Di M; Wiley Z; Gaddh M; Patzer RE; Alabi O
Therapeutic Plasma Exchange is Safe and Efficacious in Normalizing Increased Plasma Viscosity Associated with COVID-19
Volume: 156 Page(s): S8 - S9
10/01/2021 Authors: Nakahara H; Barker N; Auld S; Truong A; Daniels L; Friend S; Gaddh M; Cobb J; Connor M; Polly D
Immune thrombocytopenia in 2 healthy young women after the Pfizer-BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination.
J Am Coll Emerg Physicians Open Volume: 2 Page(s): e12531
10/01/2021 Authors: Collins EC; Carr MJ; Kim JS; Lewis J; Maleque N; Desai K; Chen L; Sevransky J; Gaddh M; Rouphael N
Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center.
JCO Oncol Pract Volume: 17 Page(s): 517 - 521
09/01/2021 Authors: Gaddh M; Maier CL
The Coronavirus Disease 2019 Likelihood of Thrombosis Calculator: Predicting Venous Thromboembolism Risk in Hospitalized Patients With Coronavirus Disease 2019
Volume: 74 Page(s): E84 - E86
09/01/2021 Authors: Meena RA; Di M; Patzer RE; Gaddh M; Nahab FB; Alabi O
COVID-19-associated venous thromboembolism portends worse survival.
Semin Vasc Surg Volume: 34 Page(s): 117 - 124
09/01/2021 Authors: Meena RA; Sharifpour M; Gaddh M; Cui X; Xie Y; Di M; Brewster LP; Duwayri Y; Alabi O
Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.
Blood Adv Volume: 5 Page(s): 2807 - 2812
07/27/2021 Authors: Houghton DE; Billett HH; Gaddh M; Onadeko O; George G; Wang T-F; Oo TH; Feng M; Dasgupta M; Jaglal M
North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy.
J Womens Health (Larchmt) Volume: 30 Page(s): 829 - 836
06/01/2021 Authors: Cohen AJ; Boggio L; Billett HH; DeSancho MT; Gaddh M; Kouides P; Lim M; Nyak L; Rajan S; Rosovsky R
Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
Thromb Res Volume: 202 Page(s): 155 - 161
06/01/2021 Authors: Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang T-F; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
JCO Oncol Pract Volume: 17 Page(s): e497 - e505
04/01/2021 Authors: Jillella AP; Arellano ML; Gaddh M; Langston AA; Heffner LT; Winton EF; McLemore ML; Zhang C; Caprara CR; Simon KS
Venous Thromboembolism: Genetics and Thrombophilias.
Semin Respir Crit Care Med Volume: 42 Page(s): 271 - 283
04/01/2021 Authors: Gaddh M; Rosovsky RP
Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
Transfusion Volume: 61 Page(s): 1029 - 1034
04/01/2021 Authors: Truong AD; Auld SC; Barker NA; Friend S; Wynn AT; Cobb J; Sniecinski RM; Tanksley C-L; Polly DM; Gaddh M
Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
Shock Volume: 55 Page(s): 316 - 320
03/01/2021 Authors: Creel-Bulos C; Auld SC; Caridi-Scheible M; Barker NA; Friend S; Gaddh M; Kempton CL; Maier CL; Nahab F; Sniecinski R
A Tale of Two Surges: Improved Mortality During Second Wave of COVID-19 Infections
Volume: 73 Page(s): E47 - E47
03/01/2021 Authors: Meena RA; Di M; Cui X; Xie Y; Ramos CR; Duwayri Y; Gaddh M; Alabi O
Markers of Coagulation and Hemostatic Activation Identify Covid-19 Patients at High Risk for Thrombotic Events
Volume: 52
03/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL
Validation of an admission coagulation panel for risk stratification of COVID-19 patients.
PLoS One Volume: 16 Page(s): e0248230
01/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL
Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.
Medicine (Baltimore) Volume: 99 Page(s): e23186
11/13/2020 Authors: Creel-Bulos C; Liu M; Auld SC; Gaddh M; Kempton CL; Sharifpour M; Sniecinski RM; Maier CL; Nahab FB; Rangaraju S
Clinician-ordered peripheral blood smears have low reimbursement and variable clinical value: a three-institution study, with suggestions for operational efficiency.
Diagn Pathol Volume: 15 Page(s): 112
09/17/2020 Authors: Beckman AK; Ng VL; Jaye DL; Gaddh M; Williams SA; Yohe SL; Zhang L; Linden MA
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
Thromb Res Volume: 191 Page(s): 156 - 159
07/01/2020 Authors: Mulder FI; van Es N; Kraaijpoel N; Di Nisio M; Carrier M; Duggal A; Gaddh M; Garcia D; Grosso MA; Kakkar AK
Clinical Utilization and Cost of Thrombophilia Testing in Patients with Venous Thromboembolism.
TH Open Volume: 4 Page(s): e153 - e162
07/01/2020 Authors: Gaddh M; Cheng E; Elsebaie MAT; Bod I
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.
J Clin Med Volume: 9
05/20/2020 Authors: Kong JH; Winton EF; Heffner LT; Gaddh M; Hill B; Neely J; Hatcher A; Joseph M; Arellano M; El-Rassi F
Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481.
Blood Adv Volume: 4 Page(s): 1093
03/24/2020
Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.
Blood Adv Volume: 4 Page(s): 477 - 481
02/11/2020 Authors: Carden MA; Gaddh M; Hoskote A; Brown M; Merrill V; Stowell SR; Chandrakasan S; Antun A; Kudchadkar R; Kotanchiyev S
An uncommon presentation of chronic myeloid leukemia.
Ann Hematol Volume: 99 Page(s): 357 - 358
02/01/2020 Authors: Christiansen JS; Gaddh M; Wells J
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
Thromb Res Volume: 185 Page(s): 13 - 19
01/01/2020 Authors: Mulder FI; van Es N; Kraaijpoel N; Di Nisio M; Carrier M; Duggal A; Gaddh M; Garcia D; Grosso MA; Kakkar AK
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
Hematol Rep Volume: 11 Page(s): 8395
11/29/2019 Authors: Jillella AP; Arellano ML; Heffner LT; Gaddh M; Langston AA; Khoury HJ; Mangaonkar A; Kota VK
Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study
Volume: 134
11/13/2019 Authors: Houghton DE; Billett HHH; Gaddh M; Onadeko O; George G; Wang T-F; Oo TH; Sun Y; Feng M; Jaglal M
Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis".
J Thromb Haemost Volume: 17 Page(s): 1007 - 1009
06/01/2019 Authors: Elsebaie MAT; Van Es N; Langston A; Bller HR; Gaddh M
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Volume: 17 Page(s): 645 - 656
04/01/2019 Authors: Elsebaie MAT; van Es N; Langston A; Bller HR; Gaddh M
Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study
Volume: 132
11/29/2018 Authors: Kreuziger LB; Gaddh M; Onadeko O; George G; Wang T-F; Oo TH; Feng M; Simpson P; Gali R; Billett HH
TREATMENT OF VENOUS THROMBOEMBOLISM DURING INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE LEUKEMIA: A SINGLE CENTER EXPERIENCE
Volume: 93 Page(s): E51 - E51
09/01/2018 Authors: Patel B; Cheng E; McLemore M; Arellano M; Heffner LT; Winton EF; Bodo I; Langston A; Kota V; Gaddh M
Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths
Volume: 130
12/07/2017 Authors: Kota V; Arellano ML; Kharkhanis P; Bolds S; Caprara CR; Simon KS; Debragga S; Gaddh M; Bernal-Mizrachi L; Heffner L
Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia
Volume: 130
12/07/2017 Authors: Kong JH; Winton EF; Heffner L; Gaddh M; Hill B; Arellano M; El-Rassi F; Kim A; Jillella A; Kota VK
Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)
Volume: 130
12/07/2017 Authors: Kong JH; Winton EF; Heffner L; Gaddh M; Hill B; Arellano ML; El-Rassi F; Kim A; Kota V
Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study
Volume: 130
12/07/2017 Authors: Raza A; Al-Kali A; Tibes R; Spitzer G; Gaddh M; Tycko B; Lee S; Galili N; Ali AM; Mears JG
Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients
Volume: 130
12/07/2017 Authors: Almuwaqqat Z; Gaddh M; Schlafer D; Hutcherson D; Arellano ML; Parashar S; Kota V
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib.
Clin Lymphoma Myeloma Leuk Volume: 17 Page(s): e71 - e73
12/01/2017 Authors: Kota VK; Kong JH; Arellano M; El Rassi F; Gaddh M; Heffner LT; Winton EF; Jillella AP; McLemore ML; Khoury HJ
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
Hematol Rep Volume: 9 Page(s): 7083
09/26/2017 Authors: Jillella AP; Arellano ML; Heffner LT; Gaddh M; Langston AA; Khoury HJ; Mangoankar A; Kota VK
Cost of Thrombophilia Workup At a Tertiary Care Hospital
Volume: 23 Page(s): 11 - 12
04/01/2017 Authors: Cheng E; Lin Y; Bodo I; Gaddh M
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
Oncogene Volume: 36 Page(s): 254 - 262
01/12/2017 Authors: Elf S; Lin R; Xia S; Pan Y; Shan C; Wu S; Lonial S; Gaddh M; Arellano ML; Khoury HJ
Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions
Volume: 128
12/02/2016 Authors: Kong JH; Khoury HJ; Winton EF; Heffner LT; Gaddh M; Arellano M; El-Rassi F; Kim AS; Jillella A; Bodo I
A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States
Volume: 128
12/02/2016 Authors: Kota V; Karkhanis P; Sharma R; Bolds S; Sitchenko K; Shrestha A; Jonnalagadda V; Gaddh M; Bernal-Mizrachi L; Heffner LT
A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States
Volume: 128
12/02/2016 Authors: Jillella A; Karkhanis P; Sharma R; Bolds S; Shrestha A; Sitchenko K; Jonnalagadda V; Gaddh M; Bernal-Mizrachi L; Heffner LT
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.
Mol Cell Volume: 64 Page(s): 859 - 874
12/01/2016 Authors: Fan J; Lin R; Xia S; Chen D; Elf SE; Liu S; Pan Y; Xu H; Qian Z; Wang M
Bleeding and thrombosis in the elderly
Nonmalignant Hematology: Expert Clinical Review: Questions and Answers Page(s): 677 - 684
08/24/2016 Authors: Gaddh M
DECREASING EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN AN ACADEMIC CENTER IN THE US BY USING A SIMPLIFIED TREATMENT ALGORITHM AND DEDICATED APL EXPERTS
Volume: 101 Page(s): 675 - 676
06/01/2016 Authors: Jillella A; Mody M; Harpaul G; Arellano M; Khoury H; Al-Kadhimi Z; McLemore M; Winton E; Gaddh M; Heffner L
Costs associated with induction chemotherapy in adult acute myeloid leukemia (AML) managed in a tertiary care specialized unit.
Volume: 34
05/20/2016 Authors: Gleason S; Howard DH; Liu Y; Goldstein DA; Arellano ML; Jillella AP; Gaddh M; Kota V; Winton EF; Heffner LT
Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience
Volume: 126
12/03/2015 Authors: Zeichner SB; Gleason S; Antun AG; Langston A; Heffner LT; Kota VK; Gaddh M; Arellano M
Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA
Volume: 126
12/03/2015 Authors: Jillella A; Arellano M; Bashey A; Vidito SI; Stuart RK; Leung C; Sitchenko K; Gaddh M; Heffner LT; Kolhe RB
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?
Cancer Volume: 121 Page(s): 872 - 875
03/15/2015 Authors: El Rassi F; Bergsagel JD; Arellano M; Gaddh M; Jillella A; Kota V; Heffner LT; Winton EF; Khoury HJ
Peripheral T Cell Lymphoma Masquerading As Asthma And Eosinophilia
Volume: 191
01/01/2015 Authors: Egea E; Sica G; Gaddh M; Bag R; Lee F-H
Disposable platform provides visual and color-based point-of-care anemia self-testing.
J Clin Invest Volume: 124 Page(s): 4387 - 4394
10/01/2014 Authors: Tyburski EA; Gillespie SE; Stoy WA; Mannino RG; Weiss AJ; Siu AF; Bulloch RH; Thota K; Cardenas A; Session W
Early Blast Phase Transformation In Chronic Phase Chronic Myeloid Leukemia: Is Flow Cytometry The Missing Link?
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 14 Page(s): S136 - S137
09/01/2014 Authors: El Rassi F; Arellano M; Winton E; Heffner L; Gaddh M; Khoury HJ
Venous access catheter-related thrombosis in patients with cancer.
Leuk Lymphoma Volume: 55 Page(s): 501 - 508
03/01/2014 Authors: Gaddh M; Antun A; Yamada K; Gupta P; Tran H; El Rassi F; Kim HS; Khoury HJ
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
Mol Cell Volume: 53 Page(s): 534 - 548
02/20/2014 Authors: Fan J; Shan C; Kang H-B; Elf S; Xie J; Tucker M; Gu T-L; Aguiar M; Lonning S; Chen H
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Cancer Volume: 119 Page(s): 3784 - 3787
11/01/2013 Authors: Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT
Evaluation of 4Tscore and Polytypic Solid-Phase Elisa Test in the Diagnosis of Heparin-Induced Thrombocytopenia
AMERICAN JOURNAL OF HEMATOLOGY Volume: 87 Page(s): S172 - S172
05/01/2012 Authors: Gaddh M; Poola H; Jain P; Velinova S; Kovarik P; Telfer M; Catchatourian R
Frequency distribution of hepatitis C infection among patients with B-cell non-Hodgkin lymphoma in underserved minority population
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Adab K; Chongpison Y; Patel AV; Gaddh M; Braik T; Haidau A; Poola HV; Nathan S; Telfer MC; Catchatourian R
Frequency of Kras mutation in colorectal cancer patients in a minority-based population at a community clinical oncology program (CCOP)-participating inner-city hospital.
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Gaddh M; Poola HV; Batra KK; Mullane MR; Sekosan M; Lad TE
Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults
Volume: 116 Page(s): 741 - 742
11/19/2010 Authors: Yim B; Navaleza A; Haidau A; Sreenivasappa S; Kassem MA; Ciobanu BC; Braik T; Gaddh M; Rubinstein PG; Shah M
Clinical presentation characteristics and prognosis of urban, minority patients presenting with triple-negative breast cancer: An observational 5-year case review
Volume: 26
05/20/2008 Authors: Nathan S; Patel P; Gaddh M; Yim B; Zayat V; Ferrer K; Sekosan M; Samuel J
Retrospective review of hypercoagulability in minority populations at an inner city hospital's general hematology clinic
Volume: 110 Page(s): 61B - 61B
11/16/2007 Authors: Patel PR; Gaddh M; Nathan S; Decebal G; Catchatourian R; Telfer MC

Directory section navigation

Profile

Manila Gaddh

Academic Appointment

Education

Degrees

Research

Focus

Publications